News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chemokine Therapeutics Corp. (CTI.TO) Engages Investment Banker


10/22/2008 4:07:27 PM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 22, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX:CTI)(OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announces the engagement of Boenning & Scattergood Inc. as its exclusive advisor to assist the Company in the implementation of previously announced strategic financial initiatives.

Read at Market Wired

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES